1-20 of 976
Myeloid Neoplasia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clec12a is required for the pathogenesis of NUP98::NSD1 AML

Open Access
Sagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, Courteney K. Lai, Basem Othman, Harish Sudarsanam, Thomas Eder, Florian Grebien, Daniel B. Lipka, Reinhard Henschler, Michael Heuser
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3887–3899.
https://doi.org/10.1182/bloodadvances.2024015739
Published: 2025
Includes: Supplemental data
Journal Articles

A revised prognostic model for patients with acute myeloid leukemia and first relapse

Open Access
Niek G. van der Maas, Dimitri Breems, Clara P. W. Klerk, Thomas Pabst, Patrycja Gradowska, Abin Thomas, Bart J. Biemond, Jurgen Kuball, Catharina H. M. J. Van Elssen, Otto Visser, Marie-Christiane Vekemans, Carlos Graux, Johan Maertens, Steven Knapper, Mike Dennis, Sylvie Freeman, Ian Thomas, H. Berna Beverloo, Gerwin Huls, Charles Craddock, Peter J. M. Valk, Paresh Vyas, Nigel Russell, Gert Ossenkoppele, Bob Löwenberg, Jan J. Cornelissen, Jurjen Versluis
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3853–3864.
https://doi.org/10.1182/bloodadvances.2025015797
Published: 2025
Includes: Supplemental data
Journal Articles

Real-world effectiveness of immunoglobulin replacement for hypogammaglobulinemia and infections in multiple myeloma

Open Access
Elizabeth O’Donnell, Thais Gift, Zaid Yousif, Nikhil Khandelwal, Raj Desai, Lynn Huynh, Louise Clear, Megan Pinaire, Mingchen Ye, Azeem Banatwala, Gregory Belsky, Yichuan Grace Hsieh, Christopher Herrick, Mei Sheng Duh, Shawn N. Murphy, Marie Sanchirico
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3780–3789.
https://doi.org/10.1182/bloodadvances.2024015477
Published: 2025
Includes: Supplemental data
Journal Articles

Drug development for leukemia: comprehensive analysis of clinical trials from first report to drug approval

Open Access
Clinical Trials & Observations
Kellen Cristine Tjioe, Marisol Miranda-Galvis, Kenza Mamouni, Thalyta Freitas, Muhannad Sharara, Brenda Santellano, Claudia Guillén-Lopez, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3810–3813.
https://doi.org/10.1182/bloodadvances.2024014340
Published: 2025
Includes: Supplemental data
Journal Articles

RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm

Open Access
Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal Patnaik, Mithun Shah, Devendra K. Hiwase
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3814–3818.
https://doi.org/10.1182/bloodadvances.2025016374
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis

Open Access
Yosra M. Aljawai, Jeremy Ramdial, Gabriela Rondon, Portia Smallbone, Partow Kebriaei, Uday Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta
Journal: Blood Advances
Blood Adv (2025) 9 (15): 4023–4036.
https://doi.org/10.1182/bloodadvances.2025016236
Published: 2025
Includes: Supplemental data
Journal Articles

Ethical Considerations for Hematologic Precursor Conditions

Open Access
Eric C. Blackstone, Lachelle D. Weeks, Amy E. DeZern, Gregory A. Abel
Journal: Blood Advances
Blood Adv bloodadvances.2025017215.
https://doi.org/10.1182/bloodadvances.2025017215
Published: 2025
Includes: Supplemental data
Journal Articles

Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML

Open Access
Abdulrahman Alhajahjeh, Kishan Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes M Mendez, Stuart E Seropian, Lohith Gowda, Scott F. Huntington, Maximilian F. Stahl, Amer M Zeidan, George Goshua, Jan P. Bewersdorf
Journal: Blood Advances
Blood Adv bloodadvances.2025016532.
https://doi.org/10.1182/bloodadvances.2025016532
Published: 2025
Includes: Supplemental data
Journal Articles

Somatic Mutations in STAG2 Are Associated with Separated Megakaryocyte Nuclear Lobes in Myelodysplastic Syndromes

Open Access
Waihay J Wong, Rebecca L Zon, Christopher J. Gibson, Caleb Ho, Olga Pozdnyakova, Donna S. Neuberg, Elisabeth M. Battinelli, Marlise R. Luskin, Zuzana Tothova, Elizabeth A. Morgan, Benjamin L Ebert
Journal: Blood Advances
Blood Adv bloodadvances.2025016897.
https://doi.org/10.1182/bloodadvances.2025016897
Published: 2025
Includes: Supplemental data
Journal Articles

Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia

Open Access
Emma L. Boertjes, Christian M Vonk, François G. Kavelaars, Marie Engvall, Sofia Nordin, Lisanne Beugelink, Melissa Rijken, Jolinda Konijnenburg, Jurjen Versluis, Bob Löwenberg, Peter J.M. Valk
Journal: Blood Advances
Blood Adv bloodadvances.2025016726.
https://doi.org/10.1182/bloodadvances.2025016726
Published: 2025
Includes: Supplemental data
Journal Articles

Targeting bone marrow mesenchymal stromal cells-derived IL-6 to overcome acute myeloid leukemia chemoresistance

Open Access
Diyu Hou, Danni Cai, Wei Dai, Xinai Liao, Maoqing Tan, Xiaoming Zheng, Liuhuan Wang, Jingru Liu, Jin Wang, Xiaoting Wang, Qiang Fu, Huifang Huang
Journal: Blood Advances
Blood Adv bloodadvances.2024015496.
https://doi.org/10.1182/bloodadvances.2024015496
Published: 2025
Includes: Supplemental data
Journal Articles

NTRK1 -rearranged histiocytosis: clinicopathologic and molecular features

Open Access
Clinical Trials & Observations
Rivers Fragneau, Sylvie Fraitag, Paul G. Kemps, Zofia Hélias-Rodzewicz, Somak Roy, Benjamin Bonsang, Allison L. Bartlett, Subhra Dhar, Martin Jankofsky, Jozef Zlocha, Karel Svojgr, Lenka Krsková, Andrica C. H. de Vries, Robert M. Verdijk, Jan A. M. van Laar, Roos J. Leguit, Philippe Drabent, Eric D. Carlsen, Jonhan Ho, Arivarasan D. Karunamurthy, Mariarita Santi, Marie-Laure Jullié, Florian Babor, Robert Lorsbach, Astrid G. S. van Halteren, Sébastien Héritier, Eli L. Diamond, Benjamin H. Durham, Ashish R. Kumar, Arunaloke Bhattacharya, Julien Haroche, Jean Donadieu, Arndt Borkhardt, Jennifer L. Picarsic, Jean-François Emile
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3617–3628.
https://doi.org/10.1182/bloodadvances.2025016167
Published: 2025
Includes: Supplemental data
Journal Articles

Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine

Open Access
Clinical Trials & Observations
Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette, Lorea Aguinaga, Arij Cheffai, Clémentine Chauvel, Reinaldo Dal Bello, Emmanuel Raffoux, Emmanuelle Clappier, Matthieu Duchmann, Pierre Fenaux, Pierre Lemaire, Stephanie Mathis, Marie Sébert, Lionel Adès, Raphaël Itzykson
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3556–3565.
https://doi.org/10.1182/bloodadvances.2024015734
Published: 2025
Includes: Supplemental data
Journal Articles

Platelet glycosylation in myelodysplastic syndromes correlates with disease severity

Open Access
Katelyn E. Rosenbalm, Tin Long Wong, Donny Hoang, Valerie L. Andersen, George Steinhardt, Shikan Zheng, Elizabeth A. Griffiths, Tongjun Gu, Karin M. Hoffmeister, Joseph T. Lau, Michael J. Nemeth
Journal: Blood Advances
Blood Adv bloodadvances.2025016349.
https://doi.org/10.1182/bloodadvances.2025016349
Published: 2025
Includes: Supplemental data
Journal Articles

Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia

Open Access
Guillermo Montalban-Bravo, Sanam Loghavi, Ziyi Li, Kelly Sharon Chien, Rashmi Kanagal-Shamanna, Alex Bataller, Anuya Natu, Mark Gurney, Alexandre Bazinet, Danielle Hammond, Koji Sasaki, Gautam Borthakur, Mahesh Swaminathan, Courtney D. DiNardo, Tapan M. Kadia, Farhad Ravandi, Naval G Daver, Nicholas J. Short, Naveen Pemmaraju, Ghayas C. Issa, Terra L Lasho, Christy M. Finke, Aref Al-Kali, Clifford M Csizmar, Hassan B Alkhateeb, Naseema Gangat, Abhishek A. Mangaonkar, Carlos E. Bueso-Ramos, Ayalew Tefferi, Hagop M Kantarjian, Guillermo Garcia-Manero, Mrinal M Patnaik
Journal: Blood Advances
Blood Adv bloodadvances.2025016529.
https://doi.org/10.1182/bloodadvances.2025016529
Published: 2025
Includes: Supplemental data
Journal Articles

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

Open Access
Anmol Baranwal, Kimberly J. Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich, Caner Saygin, Mariam Nawas, Talha Badar, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Vivek Roy, James M. Foran, Hemant S. Murthy, Madiha Iqbal, Jeanne Palmer, Lisa Z. Sproat, Saurabh Chhabra, Nandita Khera, Mehrdad Hefazi, Abhishek Mangaonkar, William Hogan, Mark Litzow, Hassan Alkhateeb, Ayalew Tefferi, Chung Hoow Kok, Guru Subramanian Guru Murthy, Anand Patel, Ashish Bajel, Devendra K. Hiwase, Mithun Vinod Shah
Journal: Blood Advances
Blood Adv (2025) 9 (14): 3395–3407.
https://doi.org/10.1182/bloodadvances.2024015335
Published: 2025
Includes: Supplemental data
Journal Articles

Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations

Open Access
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, Monika M. Kutyna, Aref Al-Kali, Carla Toop, Patricia Greipp, Anna Brown, Syed Shah, Shreyas Khanna, Dariusz Ladon, Vedavyas Gannamani, Dong Chen, Kebede Begna, Zoe K. Price, Danielle Rud, Mark R. Litzow, William J. Hogan, Peter Bardy, Talha Badar, Sharad Kumar, David T. Yeung, Mrinal M. Patnaik, James M. Foran, Rong He, Naseema Gangat, Hamish S. Scott, Cecilia Y. Arana Yi, Hassan Alkhateeb, Abhishek A. Mangaonkar, Daniel Thomas, Christopher N. Hahn, Attilio Orazi, Daniel A. Arber, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3370–3380.
https://doi.org/10.1182/bloodadvances.2024015238
Published: 2025
Includes: Supplemental data
Journal Articles

Can we harmonize classification of TP53 mutant MDS/AML?

Open Access
David A. Sallman
Journal: Blood Advances
Blood Adv (2025) 9 (13): 3381–3382.
https://doi.org/10.1182/bloodadvances.2025016336
Published: 2025
Journal Articles

Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: A longitudinal registry-based analysis

Open Access
Priya H Marathe, Anne S. Reiner, Dana Bossert, Allison M Sigler, Deanna Fournier, Kathleen Brewer, Gaurav Goyal, Thomas M Atkinson, Jun Mao, Katherine S Panageas, Eli L Diamond
Journal: Blood Advances
Blood Adv bloodadvances.2024015659.
https://doi.org/10.1182/bloodadvances.2024015659
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

Open Access
Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K Singh, Mark R Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey L. Uy, Edmund K Waller, Sumithira Vasu, Melhem M. Solh, Asmita Mishra, Lori S. Muffly, Hee-Je Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Kirsty J Thomson, Caroline Chen, Nahla Hasabou, Matt Rosales, Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Adam M Mendizabal, Steven M. Devine, Mary M Horowitz, Yi-Bin Chen
Journal: Blood Advances
Blood Adv bloodadvances.2025016306.
https://doi.org/10.1182/bloodadvances.2025016306
Published: 2025
Includes: Supplemental data